Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807624 · ClinicalTrials.gov registry record · Phase 2
Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)
A Phase 2 study, sponsored by St. Renatus.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT01807624: Completed Phase 2 study, sponsored by St. Renatus.
NCT01807624 is a Phase 2 study that has completed, run by St. Renatus. The registered enrollment target is 24 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01807624, a Phase 2 study, has completed, sponsored by St. Renatus.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the pharmacokinetics/pharmacodynamics and safety of a nasal spray containing the anesthetic drug tetracaine in combination with oxymetazoline with blood draws over 24 hours.
Interventions
- DRUG Tetracaine HCl 3% and Oxymetazoline HCl 0.05%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
What the finished NCT01807624 record still lists
NCT01807624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Tetracaine HCl 3% and Oxymetazoline HCl 0.05% is the first listed.
NCT01807624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01807624 about?
NCT01807624 is a clinical study titled "Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)". The purpose of this study is to determine the pharmacokinetics/pharmacodynamics and safety of a nasal spray containing the anesthetic drug tetracaine in combination with oxymetazoline with blood draws over 24 hours.
What is the current status of trial NCT01807624?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2013-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01807624?
The interventions under investigation include: Tetracaine HCl 3% and Oxymetazoline HCl 0.05% (DRUG).
Who is sponsoring clinical trial NCT01807624?
This trial is sponsored by St. Renatus, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01807624's enrollment target sits among peer trials
24 1756th of 2000 higher than 217 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia